Fox-1 inhibitors are a class of chemical compounds that primarily target a specific protein known as Fox-1, also referred to as A2BP1 or RBFOX1. These inhibitors are designed to interact with Fox-1 at the molecular level, disrupting its normal function and potentially leading to a cascade of downstream effects in cellular processes. Fox-1 itself is a crucial regulatory protein involved in the post-transcriptional processing of RNA molecules, particularly in the alternative splicing of pre-messenger RNA (pre-mRNA). Alternative splicing is a fundamental mechanism that allows a single gene to give rise to multiple protein isoforms with distinct functions. Fox-1 helps regulate this process by binding to specific RNA sequences, known as Fox-1 binding sites, within pre-mRNAs and influencing their splicing patterns.
The inhibition of Fox-1 by these chemical compounds can have profound implications for gene expression and protein production within cells. By interfering with Fox-1's ability to bind to its target RNA sequences, Fox-1 inhibitors may alter the splicing patterns of certain genes, leading to the production of different protein isoforms than would occur under normal conditions. This can result in a wide range of cellular effects, as protein isoforms often have distinct functions and activities. Researchers are actively exploring the potential applications of Fox-1 inhibitors in various fields, including molecular biology and basic research, as they offer a powerful tool for studying the intricate mechanisms of RNA splicing and gene regulation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A potent inhibitor of phosphoinositide 3-kinases (PI3K), which can indirectly affect Fox-1 activity by modulating AKT signaling that may control alternative splicing events regulated by Fox-1. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Another PI3K inhibitor that can interfere with downstream signaling pathways influencing Fox-1-related splicing. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
An inhibitor of mitogen-activated protein kinase kinase (MEK), which can indirectly influence Fox-1 activity by altering MAPK/ERK pathway signaling, a pathway known to interact with splicing regulation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of c-Jun N-terminal kinase (JNK), which may affect transcription factors and splicing regulators indirectly related to Fox-1 function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
A p38 MAPK inhibitor that can indirectly modulate splicing events where Fox-1 is a regulatory factor. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
Inhibits MEK1/2, possibly affecting alternative splicing and indirectly the activity of Fox-1. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor that can lead to changes in the phosphorylation state of splicing factors and thereby influence Fox-1-related alternative splicing. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that can cause changes in the chromatin structure and gene expression, which may indirectly affect Fox-1-dependent splicing. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
A histone deacetylase inhibitor that can alter gene expression patterns, potentially affecting Fox-1 splicing targets. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Another histone deacetylase inhibitor that can lead to alterations in chromatin structure and gene expression, which in turn may influence Fox-1 activity. |